Case Report
Accepted on 31 Dec 2025
Telitacicept in the Treatment of cSLE-APS: Novel Therapeutic Perspectives on Autoimmune Thrombotic Diseases in Children
in B Cell Biology
Case Report
Accepted on 31 Dec 2025
in B Cell Biology
Review
Accepted on 31 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 31 Dec 2025
in Cytokines and Soluble Mediators in Immunity
Original Research
Accepted on 31 Dec 2025
in T Cell Biology
Review
Accepted on 31 Dec 2025
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Review
Accepted on 31 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 31 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 31 Dec 2025
in Cancer Immunity and Immunotherapy
Case Report
Accepted on 31 Dec 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Accepted on 31 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 31 Dec 2025
in Inflammation
Mini Review
Accepted on 31 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 31 Dec 2025
in Inflammation
Original Research
Accepted on 31 Dec 2025
in Molecular Innate Immunity
Original Research
Accepted on 31 Dec 2025
in Microbial Immunology
Original Research
Accepted on 31 Dec 2025
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Original Research
Accepted on 30 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 30 Dec 2025
in Microbial Immunology
Original Research
Accepted on 30 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 30 Dec 2025
in Inflammation
Review
Accepted on 30 Dec 2025
in T Cell Biology
Original Research
Accepted on 30 Dec 2025
in Cancer Immunity and Immunotherapy
Review
Accepted on 30 Dec 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Accepted on 30 Dec 2025
in Inflammation